Clinical Trial Update: Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing safety, tolerability, and immunogenicity of a recombinant anthrax vaccine with Anthrax Vaccine Adsorbed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax

Drugs mentioned

• Anthrax Vaccine Adsorbed (anthrax vaccine adsorbed)
• Recombinant Anthrax Vaccine (recombinant protective antigen (rPA) anthrax vaccine)

Snippet

Sponsor: PharmAthene UK Limited | Conditions: Bacillus Anthracis (Anthrax) | Phase 2 | Status: COMPLETED